Build Your Own Case Study Obesity: Treating the Whole Patient
Tracking # 20-1039936
Free
There are no ratings for this course
Learn moreCourse overview
Obesity is a chronic, progressive, relapsing disease that impacts health and quality of life. In individuals with obesity, there are many contributors to its development and persistence, including lifestyle, social, and economic factors. If left untreated, obesity can be a primary driver of serious health consequences. By treating obesity first, complications arising from obesity may improve or resolve. Given the severity of the disease, there is a need for clinicians in primary and specialty care settings to diagnose and treat obesity so that patients can receive the most appropriate treatment and care. Evidence-based treatment options, including anti-obesity medications, are emerging for adults and children. In this immersive virtual Build Your Own Case Study | Obesity: Treating the Whole Patient, navigate through your toughest clinical challenges while leading experts reinforce essential topics, such as: Medical consequences and comorbidities of obesity Application of adiposity measures, including BMI and waist circumference Latest clinical evidence of new and emerging anti-obesity medications Best practices in shared decision-making and starting the conversation with your patients
Subject areas
This course counts toward the state boards and subject areas below.
Florida Board of Medicine
Medical Doctor
Medical Doctor Limited License
Medical Doctor Public Health Certificate
Florida Board of Nursing
Advanced Practice Registered Nurse
Registered Nurse
Florida Board of Pharmacy
Pharmacist
Disclosure statements
Faculty Disclosures
Planner/Presenter
Jamy D. Ard, MD
Professor, Department of Epidemiology & Prevention
Wake Forest School of Medicine
Co-Director, Weight Management Center
Atrium Health Wake Forest Baptist
Winston-Salem, NC
Jamy D. Ard, MD, has a financial interest/relationship or affiliation in the form of:
Advisory Board/Consultant: Boehringer Ingelheim, Intuitive, Lilly, Nestle, Novo Nordisk, United Health Group, Weight Watchers
Research Grant: Epitomee, KVK Tech, Lilly, Nestle, Weight Watchers
The following relationships have ended within the last 24 months:
Advisory Board/Consultant: Calibrate
Scott Kahan, MD, MPH
Director, National Center for Weight and Wellness
Washington, DC
Scott Kahan, MD, MPH, has a financial interest/relationship or affiliation in the form of:
Advisory Board/Consultant: Currax, Gelesis, Lilly, Vivus
Holly F. Lofton, MD, DABOM
Clinical Associate Professor of Surgery and Medicine
Director, Medical Weight Management Program
NYU Langone Weight Management Program
New York, NY
Holly F. Lofton, MD, DABOM, has a financial interest/relationship or affiliation in the form of:
Advisory Board/Consultant: Novo Nordisk
Research Grant: Lilly, Novo Nordisk
Speakers’ Bureau: Novo Nordisk
The following relationships have ended within the last 24 months:
Advisory Board/Consultant: Currax
Jay H. Shubrook, DO, FACOFP, FAAFP
Professor, Primary Care Department
Diabetologist
Touro University California
College of Osteopathic Medicine
Vallejo, CA
Jay H. Shubrook, DO, FACOFP, FAAFP, has a financial interest/relationship or affiliation in the form of:
Advisory Board/Consultant: Abbott, Bayer, Nevro, Novo Nordisk
Independent Contractor: Abbott
The following relationships have ended within the last 24 months:
Advisory Board/Consultant: AstraZeneca
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from Medical Learning Institute, Inc., the accredited provider, do not have any relevant financial relationship(s) to disclose with ineligible companies unless listed below.
All of the relevant financial relationships of individuals for this activity have been mitigated.